COSIG CONFERENCE BROCHURE.pdf - Drexel University College ...
COSIG CONFERENCE BROCHURE.pdf - Drexel University College ... COSIG CONFERENCE BROCHURE.pdf - Drexel University College ...
COSIG Co-Occurring Disorders Conference, Hershey PA, May 15-17, 2006 The Surgeon General (2001) observed… • “…few clinical trials have evaluated response of African-Americans [and other minorities] to evidencebased treatments.” • “ …few studies have examined the impact of treatments on African-American [and other minorities] delivered under the usual conditions of community treatment.” • “More remains to be learned about when and how treatment must be modified…” The Surgeon General (2001) Mental Health: Culture, Race and Ethnicity. U.S. Department of Health and Human Services. Some facts… • Approximately 2% substance users have mental health problems. • Of the 2% with mental health problems • Only 8% treated for SUD problems. • Only 7% treated for MH problems. • Of the 3% substance users with serious mental health problems • 24% treated for SUD conditional on treatment of MH difficulties. • 46% treated for MH conditional on treatment of SUD problems. Analysis of 2001-2002 National Survey of Drug Use & Health (N = 90,277; Harris & Edmund, 2005) More… Behavioral treatments for SUD appear effective… • Drug users with mental health problems and without health insurance most frequently are treated by self-help groups or in human service settings. Analysis of 1999 National Household Survey Survey on Drug Abuse (N = 24,282; Wu & Ringwalt, 2005) • All studies demonstrate that patients who remain in treatment the longest have the best outcomes (DATOS; Simpson et al 1997) • Greater frequency of individual and group counseling reduces relapse (McLelland et al, 1988; Fiorentine and Anglin, 1996). • Participation in Motivational Enhancement Therapy, Relapse Prevention and Community Reinforcement Approaches (voucherbased) are addiction therapies with demonstrated effectiveness. • Participating in AA/NA and other self-help improves drug use outcome (Project MATCH Research group, 1997). • Supplemental social services decrease likelihood of relapse (McLelland et al 1997). • Proper medication (Strain, 1996). Some current evidence-based treatments are… What are the features of Relapse Prevention… • Two decades of research has supported the idea that brief therapies for substance using individuals are as effective those of longer durations (Project MATCH, NIAAA). • The addictions field endeavors to describe the critical conditions necessary and sufficient to induce change. • Motivational Enhancement Therapy, Relapse Prevention Community Reinforcement Approaches are addiction therapies designed to incorporate the critical components of change into a brief therapeutic intervention. • Foster motivation for abstinence. • Teach coping skills: recognize high-risk situations and develop alternatives. • Train in management of urges to use. • Recognize situations increasing negative affect and provide means for managing these situations. • Improve interpersonal functioning and enhance social support. • Change reinforcement contingencies: alter lifestyle. 2
COSIG Co-Occurring Disorders Conference, Hershey PA, May 15-17, 2006 What are the essential features of the Community Reinforcement Approach (CRA)… • Provide reinforcement for abstinence (vouchers). • The ABCs of behavior: functional analysis • Antecedents (Triggers) • Behaviors • Consequences (Positive reinforcers; Negative reinforcers; Positive punishers; Negative punishers) • Change reinforcement contingencies: alter lifestyle. • Family relationships • Recreational activities • Social networks • Vocational Functioning What are the basic principles of Motivational Enhancement Therapy? •Client-centered counseling approach. •Designed to help clients resolve ambivalence about treatment and ceasing drug use. •Employs strategies to evoke rapid patient directed change. •Patient directed change includes therapeutic tasks designed to accelerate patients through pre-contemplation, contemplation, and change phases. Is Motivational Enhancement Therapy effective? • Motivational interviewing and relapse prevention effective treatments for alcohol use and other substance use (Najativis & Weiss, 1977, PROJECT MATCH, 1977). • Reduces smoking in schizophrenic patients (Zeidonis, 1997). • Increases post-incarceration treatment contact in drug abusing veterans (Davis et al., 2003). The results of behavior therapy trials have been mixed in dually diagnosed populations… Positive results • Daley et al (1998) increased treatment adherence among depressed cocaine users. • Martino et al. (2000) increased treatment attendance. • Swanson et al (1998) increased attendance at 1 st outpatient appointment. Negative results • Miller et al(2003) targeted improvement in compliance among inpatient & outpatient drug using clinical populations. • Donavan et al. (2001) targeted reduction in drug use among IV users. • Booth et al. (1998) targeted reduction in opioid use among IV users. • Baker et al (2002) attempted to increase participation in substance abuse inpatient programs. We designed, piloted and evaluated a treatment that… • Considers impact of cognitive impairments in attention and memory. • Focuses on the interacting consequences of mental health and substance abuse. • Utilizes a structured “decisional balance sheet” approach to integrate substance use, adherence and mental health symptoms. • Remediates social skill and problem-solving strategy deficits. • Engages patient through behaviorally-oriented structured interventions, e.g., social skill training, successive approximations. • Integrates housing, outpatient and social services with a community reentry module. In summary, the purposes of the clinical trial were to … • Design a multi-dimensional intervention which includes elements necessary for treatment of mental illness and substance use disorder. • Include elements of motivational interviewing, relapse prevention and skill training in the intervention. • Evaluate the effectiveness of these procedures in a primarily minority clinical population and in a typical clinical environment. 3
- Page 16 and 17: COSIG Co-Occurring Disorders Confer
- Page 18 and 19: COSIG Co-Occurring Disorders Confer
- Page 20 and 21: COSIG Co-Occurring Disorders Confer
- Page 22 and 23: COSIG Co-Occurring Disorders Confer
- Page 24 and 25: COSIG Co-Occurring Disorders Confer
- Page 27: M01: The Addiction Psychiatry Couns
- Page 30 and 31: COSIG Co-Occurring Disorders Confer
- Page 32 and 33: COSIG Co-Occurring Disorders Confer
- Page 34 and 35: COSIG Co-Occurring Disorders Confer
- Page 37 and 38: COSIG Co-Occurring Disorders Confer
- Page 39 and 40: COSIG Co-Occurring Disorders Confer
- Page 41 and 42: COSIG Co-Occurring Disorders Confer
- Page 43 and 44: COSIG Co-Occurring Disorders Confer
- Page 45 and 46: COSIG Co-Occurring Disorders Confer
- Page 47: COSIG Co-Occurring Disorders Confer
- Page 51 and 52: COSIG Co-Occurring Disorders Confer
- Page 53 and 54: COSIG Co-Occurring Disorders Confer
- Page 55 and 56: COSIG Co-Occurring Disorders Confer
- Page 57 and 58: COSIG Co-Occurring Disorders Confer
- Page 59 and 60: COSIG Co-Occurring Disorders Confer
- Page 61: 5. Criminal Logic: This is a 3- to
- Page 65: COSIG Co-Occurring Disorders Confer
- Page 69 and 70: COSIG Co-Occurring Disorders Confer
- Page 71 and 72: COSIG Co-Occurring Disorders Confer
- Page 73 and 74: COSIG Co-Occurring Disorders Confer
- Page 75 and 76: 12 Roadblocks of Communication 1 Or
- Page 77 and 78: 3 G.R.A.C.E. G- For Gap. Often our
- Page 79 and 80: 5 _________________________________
- Page 81 and 82: 7 Overall, what do you gain by drug
- Page 83 and 84: 9 2. What time of day would be best
- Page 85 and 86: 11 10. What good things would happe
- Page 87 and 88: 13 Decisional Balance for Drug Use
- Page 89 and 90: 15 ________________________________
- Page 91 and 92: 17 Drug use: Antecedents, Consequen
- Page 93: Certificate of Achievement Temple U
- Page 97 and 98: COSIG Co-Occurring Disorders Confer
- Page 99 and 100: COSIG Co-Occurring Disorders Confer
- Page 101 and 102: COSIG Co-Occurring Disorders Confer
- Page 103: M06: An Overview: Co-Occurring Diso
- Page 107 and 108: Requirements for CCDP Employment CC
- Page 109 and 110: ecertification cycle (PCB approved
- Page 111 and 112: Work Experience Verification Applic
- Page 113 and 114: Code of Ethical Conduct UNLAWFUL CO
- Page 115 and 116: psychoactive substance impairs the
<strong>COSIG</strong> Co-Occurring Disorders Conference, Hershey PA, May 15-17, 2006<br />
The Surgeon General (2001) observed…<br />
• “…few clinical trials have evaluated response of<br />
African-Americans [and other minorities] to evidencebased<br />
treatments.”<br />
• “ …few studies have examined the impact of<br />
treatments on African-American [and other minorities]<br />
delivered under the usual conditions of community<br />
treatment.”<br />
• “More remains to be learned about when and how<br />
treatment must be modified…”<br />
The Surgeon General (2001) Mental Health: Culture, Race and Ethnicity.<br />
U.S. Department of Health and Human Services.<br />
Some facts…<br />
• Approximately 2% substance users have mental<br />
health problems.<br />
• Of the 2% with mental health problems<br />
• Only 8% treated for SUD problems.<br />
• Only 7% treated for MH problems.<br />
• Of the 3% substance users with serious mental health<br />
problems<br />
• 24% treated for SUD conditional on treatment of MH<br />
difficulties.<br />
• 46% treated for MH conditional on treatment of SUD<br />
problems.<br />
Analysis of 2001-2002 National Survey of Drug Use & Health (N = 90,277;<br />
Harris & Edmund, 2005)<br />
More…<br />
Behavioral treatments for SUD appear effective…<br />
• Drug users with mental health problems and<br />
without health insurance most frequently are<br />
treated by self-help groups or in human service<br />
settings.<br />
Analysis of 1999 National Household Survey Survey on Drug Abuse (N<br />
= 24,282; Wu & Ringwalt, 2005)<br />
• All studies demonstrate that patients who remain in treatment the<br />
longest have the best outcomes (DATOS; Simpson et al 1997)<br />
• Greater frequency of individual and group counseling reduces<br />
relapse (McLelland et al, 1988; Fiorentine and Anglin, 1996).<br />
• Participation in Motivational Enhancement Therapy, Relapse<br />
Prevention and Community Reinforcement Approaches (voucherbased)<br />
are addiction therapies with demonstrated effectiveness.<br />
• Participating in AA/NA and other self-help improves drug use<br />
outcome (Project MATCH Research group, 1997).<br />
• Supplemental social services decrease likelihood of relapse<br />
(McLelland et al 1997).<br />
• Proper medication (Strain, 1996).<br />
Some current evidence-based treatments are…<br />
What are the features of Relapse Prevention…<br />
• Two decades of research has supported the idea that brief<br />
therapies for substance using individuals are as effective those of<br />
longer durations (Project MATCH, NIAAA).<br />
• The addictions field endeavors to describe the critical conditions<br />
necessary and sufficient to induce change.<br />
• Motivational Enhancement Therapy, Relapse Prevention<br />
Community Reinforcement Approaches are addiction therapies<br />
designed to incorporate the critical components of change into a<br />
brief therapeutic intervention.<br />
• Foster motivation for abstinence.<br />
• Teach coping skills: recognize high-risk situations<br />
and develop alternatives.<br />
• Train in management of urges to use.<br />
• Recognize situations increasing negative affect and<br />
provide means for managing these situations.<br />
• Improve interpersonal functioning and enhance<br />
social support.<br />
• Change reinforcement contingencies: alter<br />
lifestyle.<br />
2